Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew S Alexander

Showing results (61-70 of 78) with videos related to

Pageof 8
Sort By:
Clinical & Experimental Metastasis|February 4, 2018
Pharmacologic ascorbate (P-AscH<sup>-</sup>) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinomaJustin G Wilkes, Brianne R O'Leary, Juan Du, et al.
Cell|November 20, 2015
Jagged 1 Rescues the Duchenne Muscular Dystrophy PhenotypeNatassia M Vieira, Ingegerd Elvers, Matthew S Alexander, et al.
Disease Models & Mechanisms|January 18, 2024
Standardization of zebrafish drug testing parameters for muscle diseasesMuthukumar Karuppasamy, Katherine G English, Clarissa A Henry, et al.
Muscle & Nerve|March 2, 2021
hnRNP L is essential for myogenic differentiation and modulates myotonic dystrophy pathologiesMatthew S Alexander, Rylie M Hightower, Andrea L Reid, et al.
The American Journal of Pathology|July 31, 2012
Myotubularin-deficient myoblasts display increased apoptosis, delayed proliferation, and poor cell engraftmentMichael W Lawlor, Matthew S Alexander, Marissa G Viola, et al.
Human Molecular Genetics|August 9, 2020
DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologiesAndrea L Reid, Yimin Wang, Adrienne Samani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 20, 2019
The SINE Compound KPT-350 Blocks Dystrophic Pathologies in DMD Zebrafish and MiceRylie M Hightower, Andrea L Reid, Devin E Gibbs, et al.
Human Molecular Genetics|July 4, 2019
Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathyMadhurima Saha, Skylar A Rizzo, Manashwi Ramanathan, et al.
JCI Insight|September 21, 2018
A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathiesPeter R Serafini, Michael J Feyder, Rylie M Hightower, et al.
Communications Biology|December 2, 2025
Conditional Dmd ablation in muscle and brain causes profound effects on muscle function and neurobehaviorMuthukumar Karuppasamy, Katherine G English, James R Conner, et al.
Pageof 8

Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Clinical & Experimental Metastasis|February 4, 2018
Pharmacologic ascorbate (P-AscH<sup>-</sup>) suppresses hypoxia-inducible Factor-1α (HIF-1α) in pancreatic adenocarcinomaJustin G Wilkes, Brianne R O'Leary, Juan Du, et al.
Cell|November 20, 2015
Jagged 1 Rescues the Duchenne Muscular Dystrophy PhenotypeNatassia M Vieira, Ingegerd Elvers, Matthew S Alexander, et al.
Disease Models & Mechanisms|January 18, 2024
Standardization of zebrafish drug testing parameters for muscle diseasesMuthukumar Karuppasamy, Katherine G English, Clarissa A Henry, et al.
Muscle & Nerve|March 2, 2021
hnRNP L is essential for myogenic differentiation and modulates myotonic dystrophy pathologiesMatthew S Alexander, Rylie M Hightower, Andrea L Reid, et al.
The American Journal of Pathology|July 31, 2012
Myotubularin-deficient myoblasts display increased apoptosis, delayed proliferation, and poor cell engraftmentMichael W Lawlor, Matthew S Alexander, Marissa G Viola, et al.
Human Molecular Genetics|August 9, 2020
DOCK3 is a dosage-sensitive regulator of skeletal muscle and Duchenne muscular dystrophy-associated pathologiesAndrea L Reid, Yimin Wang, Adrienne Samani, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 20, 2019
The SINE Compound KPT-350 Blocks Dystrophic Pathologies in DMD Zebrafish and MiceRylie M Hightower, Andrea L Reid, Devin E Gibbs, et al.
Human Molecular Genetics|July 4, 2019
Selective serotonin reuptake inhibitors ameliorate MEGF10 myopathyMadhurima Saha, Skylar A Rizzo, Manashwi Ramanathan, et al.
JCI Insight|September 21, 2018
A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathiesPeter R Serafini, Michael J Feyder, Rylie M Hightower, et al.
Communications Biology|December 2, 2025
Conditional Dmd ablation in muscle and brain causes profound effects on muscle function and neurobehaviorMuthukumar Karuppasamy, Katherine G English, James R Conner, et al.
Pageof 8